Our findings extend beyond conventional biomarkers (e.g., CRP, D-dimer, and ferritin) by highlighting the pathophysiology-specific markers of endothelial dysfunction (MR-proADM), immune dysregulation (NLR), and lung injury (KL-6). Here, MUC1 is linked to endothelial dysfunction.